TCL Archive In Brief: Peter Fischinger Names NCI Deputy Director; ACR Moves Headquarters To Washington Area November 8, 1985
TCL Archive “Clinical research of all kinds in the IRP lacks a rigorous, centralized process for peer review.” July 21, 1995
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive In Brief: House, Senate Enact FY ’92 Budget Bills For NCI That Differ By $200 Million; Senate’s Is Higher September 27, 1991
